Have a read, companies change their manufacturing processes alot more than you think. If new trials had to be run every time it would be prohibitively expensive and generic drugs would not be financially feasible.
"I have seen SI state the exact opposite in a recent video interview."
Please share the link to this quote I have never heard SI state that a new trial will be required for 3d manufacturing.
https://www.fda.gov/media/109615/download
MSB Trading 2021 - paradigm shift, page-6073
-
- There are more pages in this discussion • 4,138 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
96.0¢ |
Change
0.025(2.67%) |
Mkt cap ! $1.096B | |||
| Open | High | Low | Value | Volume |
| 95.0¢ | 96.5¢ | 94.0¢ | $1.231M | 1.291M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 94461 | 95.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 96.0¢ | 61151 | 6 |
View Market Depth
| Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |